Allosteric Interactions between the Antagonist Prazosin and Amiloride Analogs at the Human α1A-Adrenergic Receptor

It has been demonstrated previously that amilorides can interact with a well defined allosteric site on the human α2A-adrenergic receptor. In this study, the question was explored as to whether the human α1A-adrenergic receptor also possesses an equivalent allosteric site. The six amilorides examined strongly increased the dissociation rate of the antagonist [3H]prazosin from the α1A-adrenergic receptor in a concentration-dependent manner. With the parent amiloride, the dissociation data were well fitted by an equation derived from the ternary complex allosteric model, compatible with amiloride acting at a defined allosteric site on the α1A-adrenergic receptor. In contrast, the dissociation data for [3H]prazosin in the presence of the amiloride analogs were not compatible with the equation derived from a one-allosteric-site model, but could be fitted well by an equation derived from a two-allosteric-site model. However, certain individual parameters could not be resolved. The observed dissociation rate constants increased steeply with increasing amiloride analog concentration, and in some cases the data could be fitted with a logistic equation. The slope factors calculated from such fits were 1.2 to 2.1. It is concluded that the structure-binding relationships of the amilorides at the α1A- and α2A-adrenergic receptors are different. The interactions of the five amiloride analogs, but not the parent amiloride, with the α1A-adrenergic receptor are compatible with the presence of two (but not one) allosteric sites, and is thus more complex than that found for the α2A-adrenergic receptor.

• Publication year

  2000

• Venue

  Molecular Pharmacology

• Publication date

  2000-03-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1124/MOL.57.3.436
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Subtype-selective positive cooperative interactions between brucine analogs and acetylcholine at muscarinic receptors: functional studies.

  1999cited by this paper
• Characterization of the allosteric interactions between antagonists and amiloride analogues at the human alpha2A-adrenergic receptor.

  1998cited by this paper
• Tumour necrosis factor‐α expression and cell recruitment in Sephadex particle‐induced lung inflammation: effects of dexamethasone and cyclosporin A

  1997cited by this paper
• Pharmacological pleiotropism of the human recombinant α1A‐adrenoceptor: implications for α1‐adrenoceptor classification

  1997cited by this paper
• Competition between positive and negative allosteric effectors on muscarinic receptors.

  1995cited by this paper
• Functional domains of GABAA receptors.

  1995cited by this paper
• Detection, quantitation, and verification of allosteric interactions of agents with labeled and unlabeled ligands at G protein-coupled receptors: interactions of strychnine and acetylcholine at muscarinic receptors.

  1995cited by this paper
• GABAA receptor channels.

  1994cited by this paper
• α1-Adrenoceptor classification: sharpening Occam's razor

  1994cited by this paper
• Identification of drugs competing with d-tubocurarine for an allosteric site on cardiac muscarinic receptors.

  1994cited by this paper
• Neurotransmitter-gated ion channels as unconventional allosteric proteins

  1994cited by this paper
• Role of acidic amino acids in the allosteric modulation by gallamine of antagonist binding at the m2 muscarinic acetylcholine receptor.

  1994cited by this paper
• Two allosteric modulators interact at a common site on cardiac muscarinic receptors.

  1992cited by this paper
• Monovalent cation and amiloride analog modulation of adrenergic ligand binding to the unglycosylated alpha 2B-adrenergic receptor subtype.

  1991cited by this paper
• Allosteric regulation of cloned m1-m5 muscarinic receptor subtypes.

  1991cited by this paper
• Allosteric antagonists of the muscarinic acetylcholine receptor.

  1991cited by this paper
• An aspartate conserved among G-protein receptors confers allosteric regulation of alpha 2-adrenergic receptors by sodium.

  1990cited by this paper
• Gallamine exerts biphasic allosteric effects at muscarinic receptors.

  1989cited by this paper
• Estimation of the affinities of allosteric ligands using radioligand binding and pharmacological null methods.

  1988cited by this paper
• Interactions of amiloride with alpha- and beta-adrenergic receptors: amiloride reveals an allosteric site on alpha 2-adrenergic receptors.

  1987cited by this paper
• Regulation of porcine brain alpha 2-adrenergic receptors by Na+,H+ and inhibitors of Na+/H+ exchange.

  1987cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976influential reference
• Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

  1973cited by this paper

• Characterization of a novel positive allosteric modulator of the α1A-Adrenergic receptor

  2022cites this paper
• Current Developments on the Role of α1-Adrenergic Receptors in Cognition, Cardioprotection, and Metabolism

  2021cites this paper
• α1-Adrenergic Receptors in Neurotransmission, Synaptic Plasticity, and Cognition

  2020cites this paper
• Harnessing Ion-Binding Sites for GPCR Pharmacology

  2019cites this paper
• Allosteric modulation of G protein‐coupled receptors by amiloride and its derivatives. Perspectives for drug discovery?

  2019cites this paper
• A Battle Against the Opioid Crisis: Deciphering the Molecular Control of Opioid Receptors in an Effort to Design Safer Analgesics

  2019cites this paper
• Characterization the affinity of α1A adrenoreceptor by cell membrane chromatography with frontal analysis and stoichiometric displacement model.

  2017cites this paper
• Homobivalent Conjugation Increases the Allosteric Effect of 9-aminoacridine at the α1-Adrenergic Receptors

  2017cites this paper
• Maternal separation diminishes α-adrenergic receptor density and function in renal vasculature from male Wistar-Kyoto rats.

  2017cites this paper
• Characterization of Interactions Between Taspine Derivate TPD7 and EGF Receptor by Cell Membrane Chromatography with Zonal Elution and Frontal Analysis

  2016cites this paper
• Allosteric sodium in class A GPCR signaling.

  2014cites this paper
• Selective κ Opioid Antagonists nor-BNI, GNTI and JDTic Have Low Affinities for Non-Opioid Receptors and Transporters

  2013cites this paper
• Orthosteric Binding of ρ-Da1a, a Natural Peptide of Snake Venom Interacting Selectively with the α1A-Adrenoceptor

  2013cites this paper
• Allosteric modulators of rhodopsin-like G protein-coupled receptors: opportunities in drug development.

  2012cites this paper
• Pharmacological characterization of zinc and copper interaction with the human alpha(1A)-adrenoceptor.

  2011influential citation
• Cell membrane chromatography competitive binding analysis for characterization of α1A adrenoreceptor binding interactions

  2011cites this paper
• Identification of a novel snake peptide toxin displaying high affinity and antagonist behaviour for the α2‐adrenoceptors

  2010cites this paper
• Investigating Allosteric Activation of the M1 Muscarinic Acetylcholine Receptor

  2010cites this paper
• Aspirin inhibits human bradykinin B2 receptor ligand binding function.

  2008cites this paper
• Structure–function of α1-adrenergic receptors

  2007cites this paper
• Cannabidiol is an allosteric modulator at mu- and delta-opioid receptors

  2006cites this paper
• Nonpeptide and peptide growth hormone secretagogues act both as ghrelin receptor agonist and as positive or negative allosteric modulators of ghrelin signaling.

  2005cites this paper
• Subtype-selective Noncompetitive or Competitive Inhibition of Human α1-Adrenergic Receptors by ρ-TIA*

  2004cites this paper
• Determination of allosteric interactions using radioligand-binding techniques.

  2004cites this paper
• Allosteric modulation of G-protein coupled receptors.

  2004cites this paper
• A homotropic two-state model and auto-antagonism

  2004cites this paper
• Allosteric α1-Adrenoreceptor Antagonism by the Conopeptide ρ-TIA*

  2003cites this paper
• Alpha(1)-adrenergic receptor subtypes: non-identical triplets with different dancing partners?

  2003cites this paper
• Metal Ion-mediated Agonism and Agonist Enhancement in Melanocortin MC1 and MC4 Receptors*

  2002cites this paper
• The binding site of aminergic G protein-coupled receptors: the transmembrane segments and second extracellular loop.

  2002cites this paper
• Analogs of WIN 62,577 define a second allosteric site on muscarinic receptors.

  2002cites this paper
• THE BINDING SITE OF AMINERGIC GP ROTEIN-COUPLED RECEPTORS:

  2002cites this paper
• Allosteric binding sites on cell-surface receptors: novel targets for drug discovery

  2002cites this paper
• G Protein-Coupled Receptor Allosterism and Complexing

  2002influential citation
• Allosteric modulation of A(3) adenosine receptors by a series of 3-(2-pyridinyl)isoquinoline derivatives.

  2001cites this paper
• Allosteric modulation of G-protein-coupled receptors

  2001cites this paper
• Agonist Binding and Function at the Human α2A-Adrenoceptor: Allosteric Modulation by Amilorides

  2000cites this paper
• Overview of Receptor Allosterism

  2000cites this paper
• Overview of receptor allosterism.

  2000cites this paper